These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29364839)

  • 1. The Functional Amyloid Curli Protects Escherichia coli against Complement-Mediated Bactericidal Activity.
    Biesecker SG; Nicastro LK; Wilson RP; Tükel Ç
    Biomolecules; 2018 Jan; 8(1):. PubMed ID: 29364839
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis.
    Bian Z; Brauner A; Li Y; Normark S
    J Infect Dis; 2000 Feb; 181(2):602-12. PubMed ID: 10669344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation.
    Wooster DG; Maruvada R; Blom AM; Prasadarao NV
    Immunology; 2006 Apr; 117(4):482-93. PubMed ID: 16556262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence.
    Agarwal V; Sroka M; Fulde M; Bergmann S; Riesbeck K; Blom AM
    J Biol Chem; 2014 May; 289(22):15833-44. PubMed ID: 24739385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of curli, a MHC-I-binding bacterial surface structure, on macrophage-T cell interactions.
    Johansson C; Nilsson T; Olsén A; Wick MJ
    FEMS Immunol Med Microbiol; 2001 Feb; 30(1):21-9. PubMed ID: 11172987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NlpI facilitates deposition of C4bp on Escherichia coli by blocking classical complement-mediated killing, which results in high-level bacteremia.
    Tseng YT; Wang SW; Kim KS; Wang YH; Yao Y; Chen CC; Chiang CW; Hsieh PC; Teng CH
    Infect Immun; 2012 Oct; 80(10):3669-78. PubMed ID: 22802341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congo Red Interactions with Curli-Producing E. coli and Native Curli Amyloid Fibers.
    Reichhardt C; Jacobson AN; Maher MC; Uang J; McCrate OA; Eckart M; Cegelski L
    PLoS One; 2015; 10(10):e0140388. PubMed ID: 26485271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
    Leist-Welsh P; Bjornson AB
    J Immunol; 1982 Jun; 128(6):2643-51. PubMed ID: 6210733
    [No Abstract]   [Full Text] [Related]  

  • 10. MlrA, a novel regulator of curli (AgF) and extracellular matrix synthesis by Escherichia coli and Salmonella enterica serovar Typhimurium.
    Brown PK; Dozois CM; Nickerson CA; Zuppardo A; Terlonge J; Curtiss R
    Mol Microbiol; 2001 Jul; 41(2):349-63. PubMed ID: 11489123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attachment and biofilm formation on stainless steel by Escherichia coli O157:H7 as affected by curli production.
    Ryu JH; Kim H; Frank JF; Beuchat LR
    Lett Appl Microbiol; 2004; 39(4):359-62. PubMed ID: 15355539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection.
    Ren B; McCrory MA; Pass C; Bullard DC; Ballantyne CM; Xu Y; Briles DE; Szalai AJ
    J Immunol; 2004 Dec; 173(12):7506-12. PubMed ID: 15585877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bacterial amyloid curli is associated with urinary source bloodstream infection.
    Hung C; Marschall J; Burnham CA; Byun AS; Henderson JP
    PLoS One; 2014; 9(1):e86009. PubMed ID: 24465838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111.
    Joiner KA; Fries LF; Schmetz MA; Frank MM
    J Exp Med; 1985 Sep; 162(3):877-89. PubMed ID: 3897448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prc contributes to Escherichia coli evasion of classical complement-mediated serum killing.
    Wang CY; Wang SW; Huang WC; Kim KS; Chang NS; Wang YH; Wu MH; Teng CH
    Infect Immun; 2012 Oct; 80(10):3399-409. PubMed ID: 22825444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the amyloid dye Congo red on curli, cellulose, and the extracellular matrix in E. coli during growth and matrix purification.
    Reichhardt C; McCrate OA; Zhou X; Lee J; Thongsomboon W; Cegelski L
    Anal Bioanal Chem; 2016 Nov; 408(27):7709-7717. PubMed ID: 27580606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of gamma globulin, complement component 1q, factor B, properdin, body temperature, C-reactive protein and serum amyloid alpha to the activity and the function of the human complement system and its pathways.
    Atosuo J; Karhuvaara O; Suominen E; Virtanen J; Vilén L; Nuutila J
    J Immunol Methods; 2024 Aug; 531():113709. PubMed ID: 38862098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Congo red derivative FSB binds to curli amyloid fibers and specifically stains curliated E. coli.
    Reichhardt C; Cegelski L
    PLoS One; 2018; 13(8):e0203226. PubMed ID: 30161215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.